Alpoim-Moreira, J.; Szóstek-Mioduchowska, A.; Słyszewska, M.; Rebordão, M.R.; Skarzynski, D.J.; Ferreira-Dias, G.
5-Aza-2′-Deoxycytidine (5-Aza-dC, Decitabine) Inhibits Collagen Type I and III Expression in TGF-β1-Treated Equine Endometrial Fibroblasts. Animals 2023, 13, 1212.
https://doi.org/10.3390/ani13071212
AMA Style
Alpoim-Moreira J, Szóstek-Mioduchowska A, Słyszewska M, Rebordão MR, Skarzynski DJ, Ferreira-Dias G.
5-Aza-2′-Deoxycytidine (5-Aza-dC, Decitabine) Inhibits Collagen Type I and III Expression in TGF-β1-Treated Equine Endometrial Fibroblasts. Animals. 2023; 13(7):1212.
https://doi.org/10.3390/ani13071212
Chicago/Turabian Style
Alpoim-Moreira, Joana, Anna Szóstek-Mioduchowska, Magda Słyszewska, Maria Rosa Rebordão, Dariusz J. Skarzynski, and Graça Ferreira-Dias.
2023. "5-Aza-2′-Deoxycytidine (5-Aza-dC, Decitabine) Inhibits Collagen Type I and III Expression in TGF-β1-Treated Equine Endometrial Fibroblasts" Animals 13, no. 7: 1212.
https://doi.org/10.3390/ani13071212
APA Style
Alpoim-Moreira, J., Szóstek-Mioduchowska, A., Słyszewska, M., Rebordão, M. R., Skarzynski, D. J., & Ferreira-Dias, G.
(2023). 5-Aza-2′-Deoxycytidine (5-Aza-dC, Decitabine) Inhibits Collagen Type I and III Expression in TGF-β1-Treated Equine Endometrial Fibroblasts. Animals, 13(7), 1212.
https://doi.org/10.3390/ani13071212